Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD4-positive, alpha-beta T cell | 6 studies | 19% ± 3% | |
| hematopoietic precursor cell | 3 studies | 19% ± 2% | |
| ciliated cell | 3 studies | 19% ± 1% | |
| epithelial cell | 3 studies | 24% ± 4% | |
| transit amplifying cell | 3 studies | 49% ± 22% | |
| natural killer cell | 3 studies | 32% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| liver | 3 studies | 29% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 97% | 126.96 | 563 / 578 | 90% | 6.89 | 1039 / 1155 |
| uterus | 86% | 54.26 | 147 / 170 | 97% | 15.41 | 446 / 459 |
| ovary | 83% | 51.56 | 150 / 180 | 93% | 6.50 | 400 / 430 |
| breast | 92% | 68.67 | 423 / 459 | 84% | 4.90 | 940 / 1118 |
| skin | 94% | 347.41 | 1694 / 1809 | 82% | 6.26 | 385 / 472 |
| stomach | 72% | 85.63 | 257 / 359 | 97% | 8.42 | 276 / 286 |
| intestine | 70% | 158.92 | 679 / 966 | 95% | 9.03 | 500 / 527 |
| esophagus | 61% | 134.81 | 885 / 1445 | 99% | 9.35 | 181 / 183 |
| bladder | 67% | 39.81 | 14 / 21 | 92% | 8.50 | 463 / 504 |
| thymus | 82% | 48.72 | 537 / 653 | 43% | 2.23 | 259 / 605 |
| pancreas | 23% | 11.19 | 76 / 328 | 80% | 3.92 | 142 / 178 |
| kidney | 66% | 43.58 | 59 / 89 | 35% | 1.26 | 315 / 901 |
| spleen | 100% | 265.95 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 15.68 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.67 | 1 / 1 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 10.53 | 28 / 29 |
| prostate | 84% | 58.09 | 206 / 245 | 11% | 0.37 | 53 / 502 |
| adrenal gland | 63% | 38.71 | 162 / 258 | 31% | 1.70 | 71 / 230 |
| brain | 44% | 19.84 | 1154 / 2642 | 46% | 3.92 | 324 / 705 |
| adipose | 89% | 64.17 | 1068 / 1204 | 0% | 0 | 0 / 0 |
| liver | 31% | 23.04 | 69 / 226 | 42% | 1.83 | 170 / 406 |
| peripheral blood | 71% | 448.51 | 659 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 55% | 29.90 | 739 / 1335 | 0% | 0 | 0 / 0 |
| heart | 28% | 13.97 | 244 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.19 | 5 / 80 |
| muscle | 3% | 1.17 | 24 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007059 | Biological process | chromosome segregation |
| GO_0000070 | Biological process | mitotic sister chromatid segregation |
| GO_0051382 | Biological process | kinetochore assembly |
| GO_0005634 | Cellular component | nucleus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0000939 | Cellular component | inner kinetochore |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CENPK |
| Protein name | Centromere protein K (CENP-K) (Interphase centromere complex protein 37) (Protein AF-5alpha) (p33) Centromere protein K |
| Synonyms | FKSG14 ICEN37 |
| Description | FUNCTION: Component of the CENPA-CAD (nucleosome distal) complex, a complex recruited to centromeres which is involved in assembly of kinetochore proteins, mitotic progression and chromosome segregation. May be involved in incorporation of newly synthesized CENPA into centromeres via its interaction with the CENPA-NAC complex. Acts in coordination with KNL1 to recruit the NDC80 complex to the outer kinetochore. . |
| Accessions | ENST00000396679.6 D6RBN6 ENST00000510768.5 ENST00000515497.5 ENST00000514814.5 ENST00000505960.5 Q9BS16 ENST00000509397.5 ENST00000508421.5 D6RHD3 ENST00000502997.5 D6R984 D6RC76 D6RAX0 ENST00000510354.1 ENST00000510693.5 D6RJF0 H0Y9K8 ENST00000242872.7 |
